Skip to main content
Caplight Logo









Prenosis

Prenosis

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://prenosis.com/

Last Round

Grant

Jan 29, 2026

Total Funding Raised

$55.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Prenosis is a healthcare technology company that develops integrated diagnostics and therapeutics for critical care conditions using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

sepsis diagnosisAI diagnostic softwareclinical decision supportsepsis risk assessmentmedical AIEHR integrationprecision medicinediagnostic algorithmhealth techdigital healthhealthcare analyticspredictive diagnosticsclinical workflow automationAI in healthcareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prenosis Comparables

Compare Prenosis with similar companies based on industry and business-model similarity.

Prenosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bayesian Health
90%
Ambient Clinical Analytics
88%
Cirrus Dx, Inc.
82%

Prenosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 29, 2026
Series AJan 29, 2024
GrantJul 12, 2023
GrantJun 7, 2023
VC RoundMar 9, 2022
Grant
Nov 17, 2021

Key People

Founding team and executive leadership

Angela Thomas

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    $20M raised in grant funding.

  • Dec 19, 2025

    Received the inaugural UL Enterprise Safety Science Award for Sepsis ImmunoScore.

Recent news

Latest coverage and updates

  • receives_awardAug 31, 2026

    Prenosis received award Chicago Innovation Award at 2025 Chicago Innovation Awards on Jul 1st '25.

  • launchesJul 1, 2026

    Prenosis launched Sepsis ImmunoScore on Jul 1st '24.

Prenosis Filings

Explore SEC and related filing metadata, where available.

Prenosis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prenosis's valuation, stock price, and market status.

Is Prenosis a public or private company?

Prenosis is a private company.

What is the current stock price of Prenosis?

Prenosis is a private company with no public stock price. No recent secondary market data is available.

How much is Prenosis worth (valuation)?

Valuation information for Prenosis is not publicly available.

Can I buy Prenosis stock?

Prenosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prenosis's last funding round?

Prenosis's most recent funding round was Grant on January 29, 2026.

Who are the main investors in Prenosis?

Key investors in Prenosis include PACE Healthcare Capital.

Will Prenosis IPO soon?

No public IPO plans have been announced for Prenosis.

How can I track Prenosis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prenosis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range43
Year Founded2014
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?